Hikma’s Latest Advair Setback Pushes It Closer To Rivals

Further CRL From FDA Is ‘Minor’; Cipla Filed ANDA In May

 
• By David Wallace
  
Runner
Hikma is still leading the race to get the second US generic Advair • Source: Shutterstock

More from Generics

More from Products